Lupin gets €20 million from patent deal
13 Oct 2007
Mumbai:
Drug maker Lupin Ltd has received 20 million euro ($28.4 million) from Laboratoires
Servier of France for selling additional patent rights for Perindopril.
"This
income significantly boosts the performance of the company for the current year,"
Kamal Sharma, managing director, said in a statement.